Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teva Pharmaceutical
Pharma
Teva's subdued outlook puts damper on strong 2024 results
Despite finishing strong in 2024, Teva’s cautious approach to the new year appears to have investors spooked.
Fraiser Kansteiner
Jan 29, 2025 1:13pm
Teva's Copaxone gets boxed warning for anaphylaxis risk
Jan 23, 2025 7:52am
Teva, Takeda divest generics joint venture in Japan
Dec 6, 2024 10:53am
Teva hit with €463M fine over Copaxone misconduct claims in EU
Oct 31, 2024 10:45am
Apellis hit with yet another eye drug snub in Europe
Sep 20, 2024 10:06am
Teva inks $80M opioid settlement with Baltimore
Sep 9, 2024 5:05pm
